Eonis SCID-SMA kit

FDA 510(k) K203035 · Perkinelmer, Inc.

Substantially Equivalent

510(k) numberK203035

Submission

Device name
Eonis SCID-SMA kit
Applicant
Perkinelmer, Inc.
Waltham, MA, US
Received
October 5, 2020
Decision date
November 9, 2022
Decision
Substantially Equivalent (SESE)
Type
Traditional 510(k)
Summary
510(k) summary available from FDA

Official FDA 510(k) record

Device classification

Product code
PJI – Severe Combined Immunodeficiency Disorder (Scid) Newborn Screening Test System
Device class
Class II (moderate risk)
Regulation
21 CFR 866.5930
Specialty
Immunology

A newborn screening test for severe combined immunodeficiency (SCID) intended for the detection of T-cell receptor excision circle (TREC) genomic DNA isolated from newborn blood specimens dried on filter paper. It is intended as an aid in screening newborns for severe combined immunodeficiency (SCID).

More from Perkinelmer, Inc.

510(k)DeviceDecision
K193103NeoBase 2 Non-derivatized MSMS KitNQL · Traditional 02/07/2020SE
K190335GSP Neonatal Total Galactose kitJIA · Traditional 11/06/2019SE
K190266NeoLSD MSMS KitPQW · Traditional 05/03/2019SE
K161966PerkinElmer XRpad2 4336 HWC-M Flat Panel DetectorMQB · Special 09/08/2016SE
K161942PerkinElmer, XRpad2 3025 HWC-M Flat Panel DetectorMQB · Special 09/01/2016SE
K142698PerkinElmer, XRpad 4343 F MED Flat Panel DetectorMQB · Special 10/23/2014SE
K140551Perkinelmer, Xrpad 4336 Med Flat Panel DetectorMQB · Traditional 08/01/2014SE
K121864Perkinelmer 226 Sample Collection DevicesPJC · Abbreviated 03/12/2013SE
K122495Perkinelmer XRD 1622 AP3 Med Flat Panel DetectorMQB · Traditional 11/28/2012SE
K093916Neobase Non-Derivatized MSMS Kit Model 3040-001UNQL · Traditional 08/23/2010SE

Questions and answers

When was Eonis SCID-SMA kit cleared by the FDA?

Eonis SCID-SMA kit (K203035) received a 510(k) decision of Substantially Equivalent on November 9, 2022, 765 days after the submission was received.

What is the product code of K203035?

The FDA product code is PJI – Severe Combined Immunodeficiency Disorder (Scid) Newborn Screening Test System, a Class II (moderate risk) device regulated under 21 CFR 866.5930.